AbbVie, Inc. (ABBV)
211.59
+5.22
(+2.53%)
USD |
NYSE |
Apr 08, 16:00
211.30
-0.29
(-0.14%)
Pre-Market: 20:00
AbbVie Market Cap : 374.13B for April 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 188.57B |
| Biogen, Inc. | 26.40B |
| Gilead Sciences, Inc. | 175.71B |
| Johnson & Johnson | 581.20B |
| Regeneron Pharmaceuticals, Inc. | 81.99B |
Market Cap Related Metrics
| PE Ratio | 91.93 |
| PS Ratio | 6.290 |
| Price to Free Cash Flow | 21.59 |
| Price | 211.59 |
| Earnings Yield | 1.09% |
| Operating PE Ratio | 19.17 |
| Normalized PE Ratio | 30.90 |